chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from nurse on 07 Apr 2010: This patient was vaccinated with S-OIV FLUVIRIN, (batch no: unknown), on 08 Mar 2010. On 08 Mar 2010, this patient was also vaccinated with IXIARO (manufacture unknown), (batch no: JEV08E108), 0.5 ml intramuscular and with Tetanus vaccine, (manufacture unknown, therefore considered conservatively as INN) and with TYPHORAL, (manufacture unknown) for unspecified indication. On 09 Mar 2010, this patient had presented with fever for a 24 hour period. The outcome of the event was reported as completely recovered on 10 Mar 2010. On 05 Apr 2010, this patient was second time vaccinated with IXIARO with no adverse event noted.
On 11/14/20 developed a rash over the face, upper and lower extremities, and trunk.  The rash was papular with some vesicles as well.  The rash was not itchy.  There was no associated fever.
10/15/22: Heaviness and weakness in right arm. Arm had purple hue. Soft lump in right armpit. Broken blood vessels inside of upper arm. Increased over 2 weeks. Saw PCP end of October. Send for ultrasound of arm. No sign of blood clot. 12/2/2022: Saw PCP again for same symptoms. Sent for chest MRI on 12/8/22-lungs filled with multiple pulmonary emboli. Started Eliquis same day. Saw pulmonologist on 12/16/2022. suggested possibility of link to 9/19/22 bivalent vaccine. Saw vascular surgeon. Continuing w/ Eliquis.
4AUG96 sl red rash on arms, legs, elevated temp;was given DPH by mom;5AUG96 cleared p/DPH, few lesions on legs;no fever;
2 days p/vax pt devel area of redness/edema 8cm in diameter; tx included Kelfex, APAP & warm compresses; incident followed final (5th) DTP vax;
On March 7th I broke out in a rash on the inside of my arms and on my legs. At first I thought it was something like bug bites, but the rash nor the bumps ever cleared up. I went to the dermatologist and we did a thorough history of my symptoms and exposure. She took a biopsy of one of the bumps and the lab work indicated that it was consistent with Lichen Planus. Because it was so close to the date of my vaccine, she recommended that I report this as a possible VAERS.
I was 1.5 years into menopause and started having tender breasts, tired, headache, cramps. I recognized that feeling all to well. Cramps started coming on stronger and then I started spotting and went into a full typical for what I used to have. And as I stated before I was almost one and a half years without having a period and had a hormonal test done and that had shown by my hormone levels that I was in fact post menopausal. It's been 21 days since that happened and I have started having the same symptoms again.  My last moderna shot was in May of 2021.
In August of 2022, the smaller toes on my right foot felt different. Not quite numb, but they felt stiff. That progressed across the front of my foot to my large toe in around a week. A week later, I began to experience the same kind of pain and numbness in my other foot. I held off as long as I could, but eventually went to see my doctor who advised I see an orthopedic doctor. I did that, and he couldn't do anything for me. I went back to my normal doctor who prescribed a nerve blocker while I wait to see a neurologist. I haven't seen a neurologist yet, but so far it has not gotten worse or better. I've been wearing compression socks and taking Gabapentin.
Palpable purpuric rash, Joint pain, blood and protein in urine. Diagnosed with Henoch Schonlein purpura.
Patient brought to the attention of charge nurse @ 1430. Patient returned to the site after receiving the vaccine at 1120 at Medical Center. Patient waited in observation after vaccination without incident. Patient stated that she was wearing pants and did not notice redness to her legs and back until about an hour after vaccination. Patient and her husband decided to come back to the site for help. Patient presented with slightly red rash to legs and back and stated she felt a headache, slight dizziness and nausea. Patient guided to chair and vitals assessed.  BP 101/84, Pulse 62, SaO2 96%, Resp 18, lung sounds clear. Patient given 25 mg of Benadryl and water, tolerated well. Patient agreed to wait 30 minutes on site. Nurse left to observe patient. Vitals @ 1500, 155/84, Pulse 63, SaO2 98%, T 98.3 F, redness and nausea improving. Patient tolerated medication well. After 30 min patient stated skin redness significantly improved and is no longer nauseous. Vitals before leaving site, BP 135/81, P 62, SaO2 98%, Temp 98.1, Resp 16, lung sounds clear. Patient educated to seek medical attention if side effects continue or worsen. Patient left site with her partner without incident.
On February 14, I started having a sore throat cough, some nasal drainage, excess mucus, no fever, not really tired. On February 16th I used a home COVID-19 test that came back positive. I called my doctor who advised me to take MUCINEX DM, ADVIL or TYLENOL as needed, stay well hydrated. I quarantined, away from everyone and I retested and was negative by February 24, 2023. I am now back to exercising an hour and a half a day, not short of breath.
Patient states that after injection she felt face felt puffy, dull pain in different areas of body, hard time processing words, chest discomfort, felling nausea and vomiting, temp 99.9, Day 2 pressure in head chest tightness, body aches, blood pressure 150/88, As of feb 2 she states she has fatigue and exhaustion, intermittent pain throughout body, left eye blurry vision, weight gain, chest discomfort
Mild numbing in hands, feet and face, on and off for 2 days.  1st pregnancy, 27 weeks pregnant, due June 19th. Currently have swelling in hands and feet due to pregnancy.
Chin and lip remain swelling; Chin and lip remain swelling; my tongue swell immediately after a week; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Medical history included allergy and bleed clots. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for covid-19 immunisation on an unspecified date. Patient received both shots. After receiving the second shot his/her tongue swelled immediately, after a week the tongue swelling went down but the chin and lip remained swelling. Patient had allergy and bleed clots before shot so he/she's being patience. Patient doesn't know whether he/she should continue receiving this shot in the near future. Outcome of tongue swelling was recovered after a week. Outcome of other events was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 11 year old female with a history of fainting, who on 12-MAY-2008 was vaccinated with a first dose of GARDASIL. Concomitant vaccination included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. On 12-MAY-2008 the nurse had the patient wait for around five minutes post vaccination. The nurse left the room for a second. The patient fainted and fell off of the exam table. The patient was found lying face down and started to turn blue, but had a pulse. The patient was rushed to the hospital and ended up having a maxillary fracture. At the time of the report, the outcome of the patient was unknown. No product quality complaint was involved. The physician considered the fainting, fall off the exam table, turning blue, and maxillary fracture to be other important medical events. Additional information has been requested.
Moderna Monovalent was charted in patient's chart. Patient should have received Moderna Bivalent vaccine. Patient received monovalent moderna vaccine.
This case was reported by a pharmacist via call center representative and described the occurrence of skin lesion in a 64-year-old male patient who received SHINGRIX (batch number J4D5J, expiry date February 2019) for prophylaxis. On 23rd August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 26th August 2018, 3 days after receiving SHINGRIX, the patient experienced skin lesion, localized erythema and local swelling. On an unknown date, the outcome of the skin lesion was not recovered/not resolved and the outcome of the localized erythema and local swelling were unknown. It was unknown if the reporter considered the skin lesion, localized erythema and local swelling to be related to SHINGRIX. Additional information was reported as follows: Approximately 3 days after vaccination with SHINGRIX, the patient had noticed a red lesion on the front of his left shoulder. The lesion was red and swollen and approximately 4 inches from the injection site. The patient thought that this lesion might be related to the vaccine, however the reporter stated that it could be something else.
Patient reports headache beginning on the evening of the vaccination.  Headache lasted for 1 week through 4/7.  Patient indicates that they began having dizziness on the evening of vaccination and the dizziness has occurred since that point.  Patient reports adnominal pain beginning 4/8 and has persisted since symptom began.  Patient was referred to their healthcare provider for evaluation.
Left axillary node swelling/tenderness. Fever(subjective), chills, achy, left sided abdominal pain. No nausea, vomiting, or diarrhea. Norma appetite.
It was painfull; Swollen under arm; Redness at injection site; Fever between 100 and 103; Chlls; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (It was painfull), SWELLING (Swollen under arm), PYREXIA (Fever between 100 and 103), CHILLS (Chlls) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 26-Dec-2020. Concomitant products included VITAMIN D NOS and VITAMIN E NOS for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (Fever between 100 and 103) and CHILLS (Chlls). On 05-Feb-2021, the patient experienced PAIN (It was painfull), SWELLING (Swollen under arm) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, PAIN (It was painfull), SWELLING (Swollen under arm) and VACCINATION SITE ERYTHEMA (Redness at injection site) was resolving and PYREXIA (Fever between 100 and 103) and CHILLS (Chlls) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: high (Inconclusive) fever between 100 and 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
I'm not sure the vaccine had any impact one way or another.  However, will share:  On about 3/28/22 had a low grade fever, abdominal discomfort, achy joints, increased tiredness etc.  These symptoms lasted for about a week.  I took 2 covid tests during that week because i could not figure out what was wrong with me.  Then on 4/4 the abdominal pain intensified, some diarrhea, vomiting, but no fever.    After it did not get better and instead got a bit worse, I went to Urgent Care the morning of 4/6.  They determined that I was having a flare up of endometriosis, have 4.5 cm cysts on each ovary, uterine fibroids AND acute appendicitis.  I was directed to drive myself to the ER for consult and surgery.  During the surgery to remove my appendix and inspect the rest of the situation, they determined that the endo flare up caused a significant amount of hemorrhagic fluid in my abdomen thus infecting my appendix.  (For the last 3-4 months my periods have been significantly worse which is likely due to the endometriosis)
This spontaneous report as received from a medical assistant (also reported as healthcare worker) refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with doses of (Oka/Merck) VARIVAX lot number for Vaccines for Children (VFC) vaccines J013905, expiration date 30-OCT-2015 (dose and route were not reported) that had a temperature excursion. Patients were also vaccinated with improperly stored Tetanus-Diptheria vaccine (TD). No adverse effects were reported. The reporter was unable to provide any patient information or dates of vaccination. This is one of several reports received from the same reporter. Additional information has been requested.
her first dose on 07May2021. On 14May2021 the caller tested positive for the covid virus; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 07May2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 14May2021, the patient tested positive for covid-19. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 14May2021. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Patient was given the vaccines at another facility on 6/18/19. Pt presents to this clinic on 6/20/19 with a localized reaction to the administration site on the Left thigh (Kinrix). It is flat, red, warm to touch, measuring 7cm x 7cm. Pt denies pain but states it is itchy.
No adverse reaction. The patient's first dose was given on 4/13/2021 (Pfizer: EW 0158, Right arm). In registry the second dose was documented as given on 04/27/2021 (14 days after the first dose). However this dose was manually entered in record as given on 05/04/2021. The date on the consent form is not legible, appears to have been written over.
became sick with covid-19. Their taste changed, they tasted everything sweet had chills and was shaking a lot like they had a venom inside them it was very weird; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (became sick with covid-19. Their taste changed, they tasted everything sweet had chills and was shaking a lot like they had a venom inside them it was very weird) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced COVID-19 (became sick with covid-19. Their taste changed, they tasted everything sweet had chills and was shaking a lot like they had a venom inside them it was very weird) (seriousness criterion hospitalization). The patient was hospitalized on 30-Mar-2021 due to COVID-19. At the time of the report, COVID-19 (became sick with covid-19. Their taste changed, they tasted everything sweet had chills and was shaking a lot like they had a venom inside them it was very weird) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products included high blood pressure medication for an unknown indication.  It was reported that their taste changed, they tasted everything sweet had chills and was shaking a lot like they had a venom inside them it was very weird so after 5 days they went to the hospital on the 30-Mar-2021 and got tested and received antibody treatment and after 8 days they were released. They were advised to not take the second dose then but know they wonder where can they get another dose to continue being protected.  Company Comment: This spontaneous case concerns a 62-year-old female patient with no relevant medical history who experienced serious unexpected event of special interest (AESI) COVID-19. The event occurred approximately 15 days after the first dose of the Moderna COVID-19 vaccine . Rechallenge was not applicable since due to nature of the event and no information on the second dose, no rechallenge was done and thus, recurrence was not applicable. The benefit-risk relationship of the product is not affected by this report; Sender's Comments: This spontaneous case concerns a 62-year-old female patient with no relevant medical history who experienced serious unexpected event of special interest (AESI) COVID-19. The event occurred approximately 15 days after the first dose of the Moderna COVID-19 vaccine . Rechallenge was not applicable since due to nature of the event and no information on the second dose, no rechallenge was done and thus, recurrence was not applicable. The benefit-risk relationship of the product is not affected by this report
24 hours after receiving Tdap client developed body aches, chills, fever of 102.2, headache, diarrhea.  Symptoms lasted about 9 hrs.
Tinnitus, popping sound in the ear.  Two days after the vaccine it started.  it was happening once or twice a day, but has become more frequent. Symptoms started after the first shot of the Pfizer vaccine.  Will NOT be returning for the second shot.
Headache, Myalgia, Fever, CHILLS, swollen lymph nodes Narrative:
Child did well with vaccine administration, but when got off exam table and sat down on sofa, he became very pale, lost  consciousness and fell head first onto the floor. Woke up within a few seconds, but was initially confused and upset saying "what happened?' Red bump noted in center of forehead. Ice pack applied and child rested while sitting for 15 minutes. Conversing fluently and sucking on a lollipop. Examined by Dr. and cleared for discharge to home.
the second dose was given after 42 days window. might need to take another dose in 21 days (before 42 days from today)
PATIENT REPORTS HE IS HAVING MYALGIA, SHIVERING, GI INTOLREANCE, CHILLS AND RUNNY PHLEGM. HE IS NOT SURE IF HE HAS A FEVER. HE CAN'T KEEP ANY FOOD DOWN RIGHT NOW BECAUSE OF GI INTOLERANCE.
pt recv vax 24APR96 & 26APR96 pt presented to MD ofc w/a 6-8cm area on induration @ the inj site which was warm;no further details were provided;
My throat is so dry; Hit bone very sore, seemed like I was hit by a car; Vomiting; Nausea; Tired; Lethargic and tired; Sore arm; Cold; Tingling; Temperature went up to 100.4°; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), PARAESTHESIA (Tingling), LETHARGY (Lethargic and tired), BONE PAIN (Hit bone very sore, seemed like I was hit by a car) and DRY THROAT (My throat is so dry) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and s 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provide by the reporter.  Concomitant products included EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE (TRUVADA) and RIBOFLAVIN (VITAMIN B2 INJEEL) for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold), PARAESTHESIA (Tingling) and PYREXIA (Temperature went up to 100.4°). On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 15-Mar-2021, the patient experienced LETHARGY (Lethargic and tired) and FATIGUE (Tired). On 17-Mar-2021, the patient experienced VOMITING (Vomiting) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced BONE PAIN (Hit bone very sore, seemed like I was hit by a car). On 19-Mar-2021, the patient experienced DRY THROAT (My throat is so dry). The patient was treated with NAPROXEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (Cold), PARAESTHESIA (Tingling), LETHARGY (Lethargic and tired), BONE PAIN (Hit bone very sore, seemed like I was hit by a car), DRY THROAT (My throat is so dry), PAIN IN EXTREMITY (Sore arm), VOMITING (Vomiting), FATIGUE (Tired), NAUSEA (Nausea) and PYREXIA (Temperature went up to 100.4°) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Body temperature: 100.4 (High) 100.4°F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       This case was linked to MOD-2021-114531 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow-up information received on 09-May-2021 included second dose details, concomitant medication and action taken updated.
Client reports on approximately day 8 post-vaccination noticing a red spot on her L upper arm a couple of inches below her vaccination site. She said the site was warm to touch but was not painful. She was unable to say if it was swollen. When asked she said there was some minor pruritis. She stated the redness lasted 3-4 days. Today there is some diffuse pink discoloration approximately 4 cm in diameter. No warmth or swelling.
This spontaneous report was received from a medical assistant and refers to multiple unspecified patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications and drug reactions or allergies was provided. The patients received doses of improperly stored M-M-R II (recombinant human albumin (rHA)) lot # M034387, expiration date 19-JUL-2018 (dose and route of administration not reported) on 23-MAY-2017, 25-MAY-2017, 05-JUN-2017 and 06-JUN-2017. Between 18-MAY-2017 and 22-MAY-2017, the vaccines underwent a temperature excursion between 47 and 77 degrees Fahrenheit for 47 hours and 15 to 46 degrees Fahrenheit for 90 hours. There were no previous excursions reported. Digital data logger was used to record the excursion. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA000670: US-009507513-1707USA000668: US-009507513-1707USA000669.
ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 12/16/2022  -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Healthcare worker reported that on an unknown date, a patient received a booster dose of VAQTA (route and lot number were not reported) 0.5 ml, "five months" after receiving the first dose on an unspecified date. Concomitant medications were not reported. No adverse effect reported. Additional information has been requested.
17 days after 2nd shot I was taken to Hospital by ambulance.  I was diagnosed with ischemic colitis, spent 6 days then released
Took last dose of Viviotif a day late; Spontaneous report received on 10JAN2020.  A male consumer "took last dose of Vivotif a day late" (PT: Inappropriate schedule of product administration), while being on Viviotif for immunization. The consumer took the final dose of Vivotif a day late. Action taken with Vivotif with respect to reported event was not applicable. The clinical outcome of the reported event was unknown.  Company Comment: A consumer took his last dose of Vivotif a day late (Inappropriate schedule of product administration). Considering the nature of the event, the causality of the event is assessed as not applicable to Vivotif.; Sender's Comments: A consumer took his last dose of Vivotif a day late (Inappropriate schedule of product administration). Considering the nature of the event, the causality of the event is assessed as not applicable to Vivotif.